A detailed history of Legal & General Group PLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Legal & General Group PLC holds 479,118 shares of LEGN stock, worth $19.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
479,118
Previous 417,081 14.87%
Holding current value
$19.2 Million
Previous $23.4 Million 9.29%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$39.5 - $57.22 $2.45 Million - $3.55 Million
62,037 Added 14.87%
479,118 $21.2 Million
Q1 2024

May 14, 2024

BUY
$55.06 - $69.99 $36,835 - $46,823
669 Added 0.16%
417,081 $23.4 Million
Q4 2023

Feb 15, 2024

BUY
$57.25 - $69.74 $8.04 Million - $9.79 Million
140,361 Added 50.85%
416,412 $25.1 Million
Q3 2023

Nov 14, 2023

SELL
$63.16 - $76.5 $156,194 - $189,184
-2,473 Reduced 0.89%
276,051 $18.5 Million
Q2 2023

Aug 14, 2023

BUY
$46.28 - $75.01 $332,845 - $539,471
7,192 Added 2.65%
278,524 $19.2 Million
Q1 2023

May 15, 2023

BUY
$43.42 - $57.37 $2.04 Million - $2.7 Million
47,021 Added 20.96%
271,332 $13.1 Million
Q4 2022

Feb 14, 2023

BUY
$38.8 - $55.46 $358,977 - $513,115
9,252 Added 4.3%
224,311 $11.2 Million
Q3 2022

Nov 14, 2022

BUY
$38.15 - $57.1 $273,306 - $409,064
7,164 Added 3.45%
215,059 $8.77 Million
Q2 2022

Aug 22, 2022

BUY
$33.54 - $55.0 $916,044 - $1.5 Million
27,312 Added 15.12%
207,895 $11.4 Million
Q1 2022

May 16, 2022

BUY
$31.02 - $48.18 $999,247 - $1.55 Million
32,213 Added 21.71%
180,583 $6.56 Million
Q4 2021

Feb 14, 2022

BUY
$41.14 - $56.98 $6 Million - $8.31 Million
145,891 Added 5885.07%
148,370 $6.92 Million
Q2 2021

Aug 12, 2021

SELL
$25.8 - $41.09 $21,027 - $33,488
-815 Reduced 24.74%
2,479 $102,000
Q4 2020

Feb 12, 2021

BUY
$25.8 - $32.39 $84,985 - $106,692
3,294 New
3,294 $93,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.7B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.